Wang Meng, Luo Yixuan, Yu Yin, Chen Fei
CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
Stem Cells Int. 2020 Dec 24;2020:8874742. doi: 10.1155/2020/8874742. eCollection 2020.
The osteochondral tissue is an interface between articular cartilage and bone. The diverse composition, mechanical properties, and cell phenotype in these two tissues pose a big challenge for the reconstruction of the defected interface. Due to the availability and inherent regenerative therapeutic properties, stem cells provide tremendous promise to repair osteochondral defect. This review is aimed at highlighting recent progress in utilizing bioengineering approaches to improve stem cell therapies for osteochondral diseases, which include microgel encapsulation, adhesive bioinks, and bioprinting to control the administration and distribution. We will also explore utilizing synthetic biology tools to control the differentiation fate and deliver therapeutic biomolecules to modulate the immune response. Finally, future directions and opportunities in the development of more potent and predictable stem cell therapies for osteochondral repair are discussed.
骨软骨组织是关节软骨和骨骼之间的界面。这两种组织中不同的组成、力学性能和细胞表型给缺损界面的重建带来了巨大挑战。由于干细胞的可获得性及其固有的再生治疗特性,其为修复骨软骨缺损提供了巨大希望。本综述旨在突出利用生物工程方法改善骨软骨疾病干细胞治疗的最新进展,这些方法包括微凝胶封装、粘性生物墨水和生物打印,以控制干细胞的给药和分布。我们还将探索利用合成生物学工具来控制细胞分化命运并递送治疗性生物分子以调节免疫反应。最后,讨论了开发更有效、可预测的骨软骨修复干细胞治疗方法的未来方向和机遇。